Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02706561 · ClinicalTrials.gov registry record · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
A NA study of Prostate Cancer and Erectile Dysfunction, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 224
- Enrollment target
- 1
- Study location
NCT02706561: Recruiting NA study of Prostate Cancer and Erectile Dysfunction, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02706561 is a NA study of Prostate Cancer and Erectile Dysfunction that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 224 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02706561, a NA study of Prostate Cancer and Erectile Dysfunction, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test two different ways to help men with sexual rehabilitation.
Primary Outcome
The EFD score of \>= 24 will be used to indicate "good" erectile function. This is both a face valid cut-off, and a cut off that is commonly used in the literature as "good" erectile function following radical prostatectomy.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
- BEHAVIORAL three in-person sessions
- BEHAVIORAL monthly phone calls
- BEHAVIORAL Acceptance and Commitment Therapy for Erectile Dysfunction (ACT-ED)
- BEHAVIORAL Enhanced Monitoring and Education (EME)
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2015-12-08 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT02706561 shows while recruiting
NCT02706561 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaires is the first listed.
NCT02706561 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02706561 about?
NCT02706561 is a clinical study titled "Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery". The purpose of this study is to test two different ways to help men with sexual rehabilitation.
What is the current status of trial NCT02706561?
This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2015-12-08. Estimated completion is 2026-12.
What conditions does trial NCT02706561 study?
This clinical trial studies the following conditions: Prostate Cancer, Erectile Dysfunction.
What interventions are being tested in trial NCT02706561?
The interventions under investigation include: questionnaires (BEHAVIORAL), three in-person sessions (BEHAVIORAL), monthly phone calls (BEHAVIORAL), Acceptance and Commitment Therapy for Erectile Dysfunction (ACT-ED) (BEHAVIORAL), Enhanced Monitoring and Education (EME) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02706561?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02706561 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02706561's enrollment target sits among peer trials
224 203rd of 735 higher than 531 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
- NCT05559671 · 224 participants · Phase 4
Safety of the Herpes Zoster Subunit Vaccine in Lupus
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI